How can a joint european health technology assessment provide an ‘additional benefit’ over the current standard of national assessments?

HIGHLIGHTS

• who: Elaine Julian from the r-connect ltd, Basel, Switzerland have published the research: How can a Joint European health technology assessment provide an ‘additional benefit’ over the current standard of national assessments?, in the Journal: (JOURNAL)
• what: Within the survey , consistency of quantitative and qualitative comments received was high across HTA bodies, regulatory bodies, haematology/oncology societies, patient organisations and industry, indicating that there is a high level of agreement regarding the identified value drivers and evolving evidence challenges in oncology assessments.
• future: Confirmatory research aiming for additional responses in particular from . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.